ROYAL BANK OF CANADA - MATINAS BIOPHARMA HLDGS INC ownership

MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 58 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MATINAS BIOPHARMA HLDGS INC
ValueSharesWeighting
Q3 2023$1,000
-66.7%
7,490
+4.9%
0.00%
Q2 2023$3,0000.0%7,140
-6.0%
0.00%
Q1 2023$3,000
-25.0%
7,594
+2.1%
0.00%
Q4 2022$4,000
-20.0%
7,435
-5.0%
0.00%
Q3 2022$5,000
-16.7%
7,823
+3.7%
0.00%
Q2 2022$6,000
-45.5%
7,546
-42.7%
0.00%
Q1 2022$11,000
+57.1%
13,174
+84.5%
0.00%
Q4 2021$7,000
-58.8%
7,140
-46.9%
0.00%
Q3 2021$17,000
+183.3%
13,440
+88.2%
0.00%
Q2 2021$6,000
-99.3%
7,140
-99.1%
0.00%
Q1 2021$821,000
-25.6%
782,140
-3.6%
0.00%
Q4 2020$1,104,000
+81.6%
811,603
+2.3%
0.00%
Q3 2020$608,000
-1.0%
793,6400.0%0.00%
Q2 2020$614,000
+29.5%
793,640
+0.3%
0.00%
Q1 2020$474,000
-73.4%
791,040
+0.8%
0.00%
-100.0%
Q4 2019$1,782,000
+260.7%
785,140
+0.4%
0.00%
Q3 2019$494,000
-26.5%
782,140
-0.2%
0.00%
Q2 2019$672,000
-21.4%
784,0400.0%0.00%
Q1 2019$855,000
+83.5%
784,0400.0%0.00%
Q4 2018$466,000
-35.5%
784,0400.0%0.00%
Q3 2018$722,000
+112.4%
784,0400.0%0.00%
Q2 2018$340,000
-43.2%
784,040
-0.0%
0.00%
Q1 2018$599,000
+54.8%
784,154
+134.5%
0.00%
Q4 2017$387,000
-13.4%
334,393
-1.2%
0.00%
Q3 2017$447,000
-42.3%
338,565
-26.2%
0.00%
Q2 2017$775,000
-16.2%
458,783
+37.3%
0.00%
Q1 2017$925,000334,0400.00%
Other shareholders
MATINAS BIOPHARMA HLDGS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,923,000$509,9900.12%
Arkadios Wealth Advisors 1,399,000$181,8700.02%
NEVILLE RODIE & SHAW INC 1,157,332$1500.01%
Platform Technology Partners 162,410$21,1130.01%
JTC Employer Solutions Trustee Ltd 775,000$1010.01%
Main Street Financial Solutions, LLC 400,826$52,1070.01%
National Wealth Management Group, LLC 42,750$5,5580.01%
STALEY CAPITAL ADVISERS INC 400,000$52,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 754,732$98,1150.00%
HYMAN CHARLES D 79,800$10,0000.00%
View complete list of MATINAS BIOPHARMA HLDGS INC shareholders